M3 India

Polymyxins: Clinical application in serious infections: Dr. Anant Patil

In this article, Dr. Anant Patil reviews ... more» In this article, Dr. Anant Patil reviews this group of medications and details on the available evidence regarding their use in serious infections caused by gram-negative bacteria. «less

Aug 24, 2021

Share

Originals

How much do you know about Bisoprolol?: Dr. Anant Patil

Bisoprolol, a cardioselective beta-blocker... more»Bisoprolol, a cardioselective beta-blocker is used in the treatment of hypertension and chronic heart failure. In this article, Dr Anant Patil discusses the pharmacology and indications for the use of bisoprolol in patients with hypertension and chronic heart failure. «less

Jul 14, 2021

Share

Originals

6 drug classes associated with thyroid dysfunction: Dr. Anant Patil

This article throws light on the drug-indu... more»This article throws light on the drug-induced thyroid dysfunction and the possible outcomes which may help clinicians manage patients appropriately. «less

May 11, 2021

Share

Originals

Angiotensin converting enzyme (ACE) inhibitors for hypertension: Dr. Anant Patil

Dr. Anant Patil writes on the clinical use... more»Dr. Anant Patil writes on the clinical use of ACE inhibitors, commonly used for hypertension. He elaborates on the benefits, adverse events, precautions, and contraindications of the drug. «less

Mar 09, 2021

Share

Originals

Doctor Diaries: 'What COVID-19 taught me apart from science and medicine?: Dr. Anant Patil'

In a new entry of Doctor Diaries, Dr. Anan... more»In a new entry of Doctor Diaries, Dr. Anant Patil shares his experience with COVID-19, how he coped with the stress of the infection, and the important life lessons he picked up at the time. «less

Jan 24, 2021

Share

Originals

Bisphosphonates in osteoporosis- What are the indications?: Dr. Anant Patil

Dr. Anant Patil reviews oral and intraveno... more»Dr. Anant Patil reviews oral and intravenous bisphosphonates which though widely used, requires different indications and formulations based on prevalent underlying condition. «less

Oct 20, 2020

Share

Originals

GLP-1 receptor agonists- Classification, dosage, & current recommendations: Dr. Anant Patil

Dr. Anant Patil details on classification ... more»Dr. Anant Patil details on classification and dosage of GLP-1 receptor agonists for the treatment of type 2 diabetes, also summarising the latest guidelines for the therapy from national and international associations. «less

Aug 25, 2020

Share

Originals

Carbapenems: 10 questions answered on the broad spectrum antibiotic- Dr. Anant Patil

Dr. Anant Patil answers ten questions on t... more»Dr. Anant Patil answers ten questions on the broad spectrum antibiotics agent- Carbapenems used for severe, multi-drug resistant bacterial infections. «less

Jul 13, 2020

Share

Originals

Oral favipiravir for treatment of COVID-19: What is the current evidence of efficacy and safety?: Dr. Anant Patil

Dr. Anant Patil throws lights on various s... more»Dr. Anant Patil throws lights on various studies and trials that have tested the clinical efficacy and safety of the drug favipiravir, recently approved for the treatment of mild to moderate COVID-19 in India. «less

Jun 26, 2020

Share

Originals

SGLT2 inhibitors in T2DM: 10 questions answered by Dr. Anant Patil

Dr. Anant Patil answers top 10 questions o... more»Dr. Anant Patil answers top 10 questions on SGLT2 inhibitors drugs used in the management of type 2 diabetes. «less

Jun 11, 2020

Share

Originals

Metformin in T2DM: Q&A by Dr. Anant Patil

Dr. Anant Patil answers ten common questio... more»Dr. Anant Patil answers ten common questions on metformin and its use in type 2 diabetes mellitus. He also reminds healthcare professionals to refer to updated prescribing information of metformin for approved indications and use. «less

May 05, 2020

Share

Originals

Chloroquine, hydroxychloroquine and COVID-19: Dr. Anant Patil

Dr. Anant Patil writes on drugs chloroquin... more»Dr. Anant Patil writes on drugs chloroquine, hydroxychloroquine, and azithromycin, all three of which have been under the spotlight now, for their roles in the treatment of COVID-19. «less

Mar 26, 2020

Share

Originals

ACEIs, ARBs, Ibuprofen and COVID-19 infection: Dr. Anant Patil

Dr. Anant Patil throws light on the ongoin... more»Dr. Anant Patil throws light on the ongoing discussion about the use of certain drugs in the context of COVID-19, Ibuprofen being one of them. «less

Mar 20, 2020

Share

Originals

Omalizumab in chronic urticaria: Dr. Kiran Godse & Dr. Anant Patil

Here is an expert analysis from Dr. Kiran ... more»Here is an expert analysis from Dr. Kiran Godse and Dr. Anant Patil, of the recently (2019) published studies on omalizumab for their relevance and usefulness in clinical practice for Indian doctors. «less

Dec 11, 2019

Share